Vivos Therapeutics (NASDAQ:VVOS – Get Free Report) posted its quarterly earnings results on Friday. The company reported ($0.31) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.42) by $0.11, Zacks reports. The business had revenue of $5.15 million for the quarter, compared to the consensus estimate of $5.63 million. Vivos Therapeutics […]

Coeptis Therapeutics (NASDAQ:ZSQR – Get Free Report) issued its earnings results on Thursday. The company reported ($0.28) EPS for the quarter, Zacks reports. Coeptis Therapeutics had a negative return on equity of 92.29% and a negative net margin of 810.04%. Coeptis Therapeutics Price Performance ZSQR stock traded up $0.27 during mid-day trading on Thursday, reaching […]

Candel Therapeutics (NASDAQ:CADL – Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.52) EPS for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.30), FiscalAI reports. Candel Therapeutics Price Performance NASDAQ CADL traded up $1.13 during trading hours on Thursday, reaching $11.81. The company’s stock had a trading volume […]

Tango Therapeutics (NASDAQ:TNGX – Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.37) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.32) by ($0.05), FiscalAI reports. Tango Therapeutics Price Performance TNGX stock traded up $0.22 during trading on Thursday, reaching $25.80. The company had a trading […]

LogicBio Therapeutics (OTCMKTS:LOGC – Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.14) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.10), Zacks reports. LogicBio Therapeutics Trading Up 0.5% LOGC traded up $0.05 on Thursday, reaching $10.55. 127,031 shares of the company’s stock were […]

HLS Therapeutics (TSE:HLS – Get Free Report) posted its quarterly earnings data on Wednesday. The company reported C($0.03) EPS for the quarter, RTT News reports. The company had revenue of C$14.67 million for the quarter. HLS Therapeutics had a negative return on equity of 16.54% and a negative net margin of 18.42%.During the same quarter […]

Turn Therapeutics (NASDAQ:TTRX – Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.20) earnings per share for the quarter, FiscalAI reports. Turn Therapeutics Stock Performance Shares of TTRX traded up $0.32 during mid-day trading on Wednesday, hitting $10.54. 68,696 shares of the company’s stock were exchanged, compared to its average […]

Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT – Get Free Report) released its earnings results on Monday. The biotechnology company reported $0.04 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.97) by $1.01, FiscalAI reports. The firm had revenue of $15.47 million for the quarter, compared to the consensus estimate of $7.29 million. […]

Apogee Therapeutics (NASDAQ:APGE – Get Free Report) posted its quarterly earnings data on Monday. The company reported ($1.14) earnings per share for the quarter, missing the consensus estimate of ($1.07) by ($0.07), FiscalAI reports. Apogee Therapeutics Stock Down 0.1% NASDAQ:APGE traded down $0.10 on Wednesday, hitting $134.59. The stock had a trading volume of 188,030 […]

Monopar Therapeutics (NASDAQ:MNPR – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.79) EPS for the quarter, missing analysts’ consensus estimates of ($0.66) by ($0.13), FiscalAI reports. Monopar Therapeutics Trading Up 0.3% MNPR traded up $0.34 on Wednesday, hitting $114.80. 238,702 shares of the company’s stock were exchanged, compared to […]

Aprea Therapeutics (NASDAQ:APRE – Get Free Report) posted its earnings results on Wednesday. The company reported ($0.07) EPS for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.11, FiscalAI reports. Aprea Therapeutics had a negative return on equity of 61.03% and a negative net margin of 4,405.59%. Aprea Therapeutics Trading Up 2.2% NASDAQ:APRE traded […]

Mineralys Therapeutics (NASDAQ:MLYS – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($2.85) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.55) by ($2.30), FiscalAI reports. Here are the key takeaways from Mineralys Therapeutics’ conference call: Positive Sentiment: Mineralys remains on track for the December 22, […]

Intensity Therapeutics (NASDAQ:INTS – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($1.11) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.87) by ($0.24), FiscalAI reports. Here are the key takeaways from Intensity Therapeutics’ conference call: INVINCIBLE-3 is preparing to restart enrollment at limited U.S. sites within […]

Bicara Therapeutics (NASDAQ:BCAX – Get Free Report) posted its earnings results on Tuesday. The company reported ($0.82) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.82), Zacks reports. Here are the key takeaways from Bicara Therapeutics’ conference call: Management highlighted three-year follow-up data for FICERA in HPV-negative head and neck cancer, […]

Protara Therapeutics (NASDAQ:TARA – Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($0.36) EPS for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.03), FiscalAI reports. Protara Therapeutics Price Performance NASDAQ:TARA traded down $0.23 on Tuesday, hitting $3.88. 89,758 shares of the company’s stock were exchanged, compared to its […]

Tango Therapeutics (NASDAQ:TNGX – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.37) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.32) by ($0.05), FiscalAI reports. Tango Therapeutics Price Performance Shares of TNGX stock opened at $27.07 on Tuesday. The stock has a 50 day simple […]

Theravance Biopharma (NASDAQ:TBPH – Get Free Report) released its quarterly earnings results on Monday. The biopharmaceutical company reported $0.07 EPS for the quarter, meeting the consensus estimate of $0.07, Zacks reports. Theravance Biopharma had a net margin of 104.34% and a return on equity of 18.84%. Theravance Biopharma Trading Down 0.0% TBPH stock opened at […]

Iovance Biotherapeutics (NASDAQ:IOVA – Get Free Report) issued its earnings results on Thursday. The biotechnology company reported ($0.11) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.13) by $0.02, Briefing.com reports. Iovance Biotherapeutics had a negative return on equity of 40.92% and a negative net margin of 89.11%.The firm had revenue of […]

Intellia Therapeutics (NASDAQ:NTLA – Get Free Report) announced its earnings results on Thursday. The company reported ($0.80) earnings per share for the quarter, meeting the consensus estimate of ($0.80), FiscalAI reports. Intellia Therapeutics had a negative net margin of 672.16% and a negative return on equity of 58.80%. The company had revenue of $7.66 million […]

Iovance Biotherapeutics (NASDAQ:IOVA – Get Free Report) released its quarterly earnings results on Thursday. The biotechnology company reported ($0.11) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.13) by $0.02, Briefing.com reports. The firm had revenue of $198.63 million during the quarter, compared to the consensus estimate of $87.83 million. Iovance […]

Monte Rosa Therapeutics (NASDAQ:GLUE – Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.43) EPS for the quarter, missing the consensus estimate of ($0.38) by ($0.05), FiscalAI reports. Monte Rosa Therapeutics had a negative net margin of 560.85% and a negative return on equity of 48.30%. The firm had revenue […]

Denali Therapeutics (NASDAQ:DNLI – Get Free Report) announced its earnings results on Thursday. The company reported ($0.68) EPS for the quarter, missing the consensus estimate of ($0.51) by ($0.17), FiscalAI reports. The business had revenue of $3.60 million for the quarter, compared to analysts’ expectations of $2.15 million. During the same quarter in the prior […]

Janux Therapeutics (NASDAQ:JANX – Get Free Report) posted its earnings results on Thursday. The company reported ($0.35) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.25) by ($0.10), FiscalAI reports. The business had revenue of $10.27 million during the quarter, compared to analysts’ expectations of $19.07 million. Janux Therapeutics Stock Performance […]

Denali Therapeutics (NASDAQ:DNLI – Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.68) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.51) by ($0.17), FiscalAI reports. The firm had revenue of $3.60 million for the quarter, compared to analysts’ expectations of $2.15 million. During the same […]

Trevi Therapeutics (NASDAQ:TRVI – Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.11) EPS for the quarter, hitting the consensus estimate of ($0.11), FiscalAI reports. Here are the key takeaways from Trevi Therapeutics’ conference call: Clinical programs remain on track: Trevi initiated the OCEAN-1 Phase III IPF-related chronic cough trial […]

Halozyme Therapeutics (NASDAQ:HALO – Get Free Report) posted its quarterly earnings data on Thursday. The biopharmaceutical company reported $2.28 earnings per share for the quarter, topping the consensus estimate of $1.79 by $0.49, FiscalAI reports. Halozyme Therapeutics had a return on equity of 232.11% and a net margin of 24.86%.The firm had revenue of $481.00 […]

Barinthus Biotherapeutics (NASDAQ:BRNS – Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.26) EPS for the quarter, beating the consensus estimate of ($0.28) by $0.02, FiscalAI reports. Barinthus Biotherapeutics Trading Up 6.0% Shares of Barinthus Biotherapeutics stock traded up $0.03 during trading on Friday, hitting $0.60. The stock had a […]

Artiva Biotherapeutics (NASDAQ:ARTV – Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.63) earnings per share for the quarter, hitting the consensus estimate of ($0.63), FiscalAI reports. Artiva Biotherapeutics Stock Performance Shares of ARTV traded down $0.31 on Friday, reaching $11.27. The stock had a trading volume of 214,660 shares, […]

Aclaris Therapeutics (NASDAQ:ACRS – Get Free Report) posted its earnings results on Thursday. The biotechnology company reported ($0.15) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.01, FiscalAI reports. The firm had revenue of $1.63 million during the quarter, compared to analyst estimates of $1.38 million. Aclaris Therapeutics had […]

Odyssey Therapeutics (NASDAQ:ODTX – Get Free Report) posted its quarterly earnings results on Wednesday. The company reported ($1.74) earnings per share for the quarter, FiscalAI reports. Odyssey Therapeutics Stock Performance ODTX traded up $0.66 during trading on Thursday, reaching $21.55. 123,152 shares of the stock were exchanged, compared to its average volume of 254,668. The […]

Aldeyra Therapeutics (NASDAQ:ALDX – Get Free Report) issued its quarterly earnings data on Thursday. The biotechnology company reported ($0.09) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.01), FiscalAI reports. Aldeyra Therapeutics Stock Down 0.6% ALDX traded down $0.01 during midday trading on Thursday, hitting $1.59. 573,829 shares of the […]

Entrada Therapeutics (NASDAQ:TRDA – Get Free Report) issued its earnings results on Wednesday. The company reported ($1.01) earnings per share for the quarter, topping the consensus estimate of ($1.05) by $0.04, FiscalAI reports. The business had revenue of $0.90 million for the quarter, compared to analyst estimates of $2.23 million. Entrada Therapeutics had a negative […]

Context Therapeutics (NASDAQ:CNTX – Get Free Report) announced its quarterly earnings results on Wednesday. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.05), FiscalAI reports. Context Therapeutics Stock Up 11.5% CNTX traded up $0.07 during trading on Wednesday, hitting $0.69. The company’s stock had a […]

Tenaya Therapeutics (NASDAQ:TNYA – Get Free Report) released its earnings results on Wednesday. The company reported ($0.20) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.12), FiscalAI reports. The business had revenue of $1.11 million for the quarter, compared to the consensus estimate of $10.00 million. Tenaya Therapeutics Price […]

Zevra Therapeutics (NASDAQ:ZVRA – Get Free Report) announced its quarterly earnings results on Wednesday. The company reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.11 by $0.14, FiscalAI reports. The company had revenue of $39.66 million for the quarter, compared to the consensus estimate of $33.88 million. Zevra Therapeutics […]

Cyclerion Therapeutics (NASDAQ:CYCN – Get Free Report) announced its earnings results on Tuesday. The company reported ($0.41) earnings per share for the quarter, topping analysts’ consensus estimates of ($7.10) by $6.69, FiscalAI reports. Cyclerion Therapeutics had a negative net margin of 170.11% and a negative return on equity of 62.10%. Cyclerion Therapeutics Stock Up 0.9% […]

Travere Therapeutics (NASDAQ:TVTX – Get Free Report) released its earnings results on Tuesday. The company reported ($0.37) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.13) by ($0.24), Zacks reports. Travere Therapeutics had a negative return on equity of 26.16% and a negative net margin of 4.00%. Travere Therapeutics Stock Performance […]